1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2023 |
| Reihe/Periodikum: | Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
| Verlag/Hrsg.: |
BMJ Publishing Group
|
| Schlagwörter: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens / RC254-282 |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26511237 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doi.org/10.1136/jitc-2023-SITC2023.1272 |
